M
Moderna, Inc.
MRNA · NASDAQ · USD
Historical Earnings
| Quarter | Reported | EPS est | EPS act | Surprise | Rev est | Rev act | Surprise | Reaction |
|---|---|---|---|---|---|---|---|---|
| Q2 2026 | Jul 31, 2026 | -2.03 | -1.97 | +3.0% | $102.9M | $145.0M | +40.9% | +0.58% |
| Q1 2026 | May 1, 2026 | -4.45 | -3.40 | +23.6% | $236.4M | $389.0M | +64.6% | +4.25% |
| Q4 2025 | Feb 13, 2026 | -2.54 | -2.11 | +16.9% | $635.2M | $678.0M | +6.7% | +4.03% |
| Q3 2025 | Nov 6, 2025 | -1.87 | -0.51 | +72.7% | $920.9M | $1.0B | +10.3% | +0.86% |
| Q2 2025 | Aug 1, 2025 | -2.99 | -2.13 | +28.8% | $893.3M | $142.0M | −84.1% | +0.13% |
| Q1 2025 | May 1, 2025 | -2.92 | -2.52 | +13.7% | $116.7M | $107.0M | −8.3% | +2.15% |
| Q4 2024 | Feb 14, 2025 | -2.68 | -2.50 | +6.7% | $942.8M | $956.0M | +1.4% | +8.37% |
| Q3 2024 | Nov 7, 2024 | -1.91 | 0.03 | +101.6% | $1.3B | $1.9B | +48.4% | −6.86% |
Detailed View
Q3 2026Nov 6, 2026Q2 2026Jul 31, 2026+0.58%Q1 2026May 1, 2026+4.25%Q4 2025Feb 13, 2026+4.03%Q3 2025Nov 6, 2025+0.86%Q2 2025Aug 1, 2025+0.13%Q1 2025May 1, 2025+2.15%Q4 2024Feb 14, 2025+8.37%Q3 2024Nov 7, 2024−6.86%Q2 2024Aug 1, 2024Q1 2024May 2, 2024Q4 2023Feb 22, 2024
2026 Q2 Metrics
| Metric | Estimate | Actual | Surprise | Y/Y |
|---|---|---|---|---|
| Revenue | $102.9M | $145.0M | Beat +40.87% | +2.1% |
| EPS | -2.03 | -1.97 | Beat +2.96% | +7.5% |
| Diluted EPS (GAAP) | — | -1.97 | — | +7.5% |
Documents
- Earnings call transcript — Q2 2026Transcript · Jul 31, 2026 · 53 speaker turns
- 8-K — Q2 20268-K · Sep 1, 2026 · sec.gov
- 10-Q — Q2 202610-Q · Jul 31, 2026 · sec.gov
- 8-K — Q2 20268-K · Jul 31, 2026 · sec.gov
- 8-K — Q2 20268-K · Jul 8, 2026 · sec.gov